Key result
The transition from cardiac hypertrophy to heart failure is mediated by complex molecular mechanisms including cardiac myocyte loss, abnormalities of calcium handling, and myocardial ischemia/hypoxia.
Understanding the molecular mechanisms of cardiac myocyte loss, calcium handling abnormalities, and ischemia/hypoxia is crucial for developing novel therapies to prevent the transition from cardiac hypertrophy to heart failure.
Answers are grounded in this paper and cite their sources.
Progress in hypertrophy mechanisms has enabled effective therapies; leaves open precise targets needed to lower persistent heart failure mortality.
Heart failure is a condition in which the heart cannot supply enough blood to the body's organs, and is a final common consequence of various heart diseases. In the past 2 decades, much progress has been made in understanding the molecular and cellular processes that contribute to cardiac hypertrophy and heart failure, leading to the development of effective therapies. However, heart failure remains a leading cause of mortality worldwide and the precise molecular mechanisms that mediate the transition of cardiac hypertrophy to heart failure are largely undefined. This review discusses the potential mechanisms of heart failure progression focusing on (1) cardiac myocyte loss, (2) abnormalities of calcium handling, and (3) myocardial ischemia and hypoxia. These factors are closely related, and are considered to contribute to the pathogenesis of contractile dysfunction and heart failure in a cooperative manner. Elucidation of the molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure will lead to the development of novel therapeutic strategies for heart diseases.
No takes yet. Share an insight, caveat, or question.
Oka et al. (2008) conducted a review in Heart failure and cardiac hypertrophy. The transition from cardiac hypertrophy to heart failure is mediated by complex molecular mechanisms including cardiac myocyte loss, abnormalities of calcium handling, and myocardial ischemia/hypoxia.
Synapse has enriched 10 related papers. Consider them for comparative context: